Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice

Journal of Experimental Medicine

Volumn 212, Issue 2, 2015, Pages 235-252

  Dong, Yingying ^a,b   Geng, Yan ^a,c   Li, Lian ^a,d   Li, Xiaohe ^a   Yan, Xiaohua ^e   Fang, Yinshan ^a   Li, Xinxin ^a   Dong, Siyuan ^a   Liu, Xue ^a   Li, Xue ^a   Yang, Xiuhong ^a   Zheng, Xiaohong ^a   Xie, Ting ^f   Liang, Jiurong ^f   Dai, Huaping ^g   Liu, Xinqi ^a   Yin, Zhinan ^a   Noble, Paul W ^f   Jiang, Dianhua ^f   Ning, Wen ^a  

^a NANKAI UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c JIANGNAN UNIVERSITY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e TSINGHUA UNIVERSITY   (China)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; BLEOMYCIN; BONE MORPHOGENETIC PROTEIN 4; FOLLISTATIN LIKE 1; FOLLISTATIN RELATED PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 22B6; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIBODY; RESPIRATORY TRACT AGENT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; FSTL1 PROTEIN, HUMAN; PROTEIN BINDING; SMAD PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CELL ACTIVATION; CELL DAMAGE; CHRONOTHERAPY; CONTROLLED STUDY; DRUG TARGETING; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; FIBROGENESIS; GENE DELETION; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM CELL; LUNG FIBROBLAST; LUNG INJURY; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL COMMUNICATION; CELL LINE; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PULMONARY FIBROSIS; RESPIRATORY TRACT MUCOSA;

AGED; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; BLEOMYCIN; BONE MORPHOGENETIC PROTEIN 4; CELL COMMUNICATION; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; FOLLISTATIN-RELATED PROTEINS; GENE EXPRESSION; HUMANS; INFLAMMATION; LUNG INJURY; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, KNOCKOUT; MIDDLE AGED; MYOFIBROBLASTS; PHENOTYPE; PROTEIN BINDING; PULMONARY FIBROSIS; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84922717866     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121878     Document Type: Article

References (58)

1. Agostini, C., and C. Gurrieri. 2006. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc. Am. Thorac. Soc. 3:357-363. http://dx.doi.org/10.1513/pats.200601-010TK
2. Aoki, F., M. Kurabayashi, Y. Hasegawa, and I. Kojima. 2005. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am. J. Respir. Crit. Care Med. 172:713-720. http://dx.doi.org/10.1164/rccm.200412-1620OC
3. ATS/ERS. 2000. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 161:646-664. http://dx.doi.org/10.1164/ajrccm.161.2.ats3-00
4. Bonniaud, P., G. Martin, P.J. Margetts, K. Ask, J. Robertson, J. Gauldie, and M. Kolb. 2004. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am. J. Respir. Cell Mol. Biol. 31:510-516. http://dx.doi.org/10.1165/rcmb.2004-0158OC
5. Borges, F.T., S.A. Melo, B.C. Özdemir, N. Kato, I. Revuelta, C.A. Miller, V.H. Gattone II, V.S. LeBleu, and R. Kalluri. 2013. TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J. Am. Soc. Nephrol. 24:385-392. http://dx.doi.org/10.1681/ASN.2012101031
6. Bradshaw, A.D. 2012. Diverse biological functions of the SPARC family of proteins. Int. J. Biochem. Cell Biol. 44:480-488. http://dx.doi.org/10.1016/j.biocel.2011.12.021
7. Chapman, H.A. 2011. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu. Rev. Physiol. 73:413-435. http://dx.doi.org/10.1146/annurev-physiol-012110-142225
8. Clutter, S.D., D.C. Wilson, A.D. Marinov, and R. Hirsch. 2009. Follistatinlike protein 1 promotes arthritis by up-regulating IFN-gamma. J. Immunol. 182:234-239. http://dx.doi.org/10.4049/jimmunol.182.1.234
9. Costello, C.M., E. Cahill, F. Martin, S. Gaine, and P. McLoughlin. 2010. Role of gremlin in the lung: development and disease. Am. J. Respir. Cell Mol. Biol. 42:517-523. http://dx.doi.org/10.1165/rcmb.2009-0101TR
10. Dolan, V., M. Murphy, P. Alarcon, H.R. Brady, and C. Hensey. 2003. Gremlin-a putative pathogenic player in progressive renal disease. Expert Opin. Ther. Targets. 7:523-526. http://dx.doi.org/10.1517/14728222.7.4.523
11. du Bois, R.M. 2010. Strategies for treating idiopathic pulmonary fibrosis. Nat. Rev. Drug Discov. 9:129-140. http://dx.doi.org/10.1038/nrd2958
12. Farkas, L., D. Farkas, J. Gauldie, D. Warburton, W. Shi, and M. Kolb. 2011. Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs. Am. J. Respir. Cell Mol. Biol. 44:870-878. http://dx.doi.org/10.1165/rcmb.2010-0070OC
13. Gauldie, J., P. Bonniaud, P. Sime, K. Ask, and M. Kolb. 2007. TGF-β, Smad3 and the process of progressive fibrosis. Biochem. Soc. Trans. 35:661-664. http://dx.doi.org/10.1042/BST0350661
14. Geng, Y., Y. Dong, M. Yu, L. Zhang, X. Yan, J. Sun, L. Qiao, H. Geng, M. Nakajima, T. Furuichi, et al. 2011. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc. Natl. Acad. Sci. USA. 108:7058-7063. http://dx.doi.org/10.1073/pnas.1007293108
15. Goodwin, A., and G. Jenkins. 2009. Role of integrin-mediated TGFβ activation in the pathogenesis of pulmonary fibrosis. Biochem. Soc. Trans. 37:849-854. http://dx.doi.org/10.1042/BST0370849
16. Grütter, C., T. Wilkinson, R. Turner, S. Podichetty, D. Finch, M. McCourt, S. Loning, L. Jermutus, and M.G. Grütter. 2008. A cytokineneutralizing antibody as a structural mimetic of 2 receptor interactions. Proc. Natl. Acad. Sci. USA. 105:20251-20256. http://dx.doi.org/10.1073/pnas.0807200106
17. Hagimoto, N., K. Kuwano, I. Inoshima, M. Yoshimi, N. Nakamura, M. Fujita, T. Maeyama, and N. Hara. 2002. TGF-β1 as an enhancer of Fasmediated apoptosis of lung epithelial cells. J. Immunol. 168:6470-6478. http://dx.doi.org/10.4049/jimmunol.168.12.6470
18. Horan, G.S., S. Wood, V. Ona, D.J. Li, M.E. Lukashev, P.H. Weinreb, K.J. Simon, K. Hahm, N.E. Allaire, N.J. Rinaldi, et al. 2008. Partial inhibition of integrin αvβ6 prevents pulmonary fibrosis without exacerbating inflammation. Am. J. Respir. Crit. Care Med. 177:56-65. http://dx.doi.org/10.1164/rccm.200706-805OC
19. Jiang, D., J. Liang, J. Hodge, B. Lu, Z. Zhu, S. Yu, J. Fan, Y. Gao, Z. Yin, R. Homer, et al. 2004. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J. Clin. Invest. 114:291-299. http://dx.doi.org/10.1172/JCI16861
20. Jiang, D., J. Liang, J. Fan, S. Yu, S. Chen, Y. Luo, G.D. Prestwich, M.M. Mascarenhas, H.G. Garg, D.A. Quinn, et al. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11:1173-1179. http://dx.doi.org/10.1038/nm1315
21. Kage, H., and Z. Borok. 2012. EMT and interstitial lung disease: a mysterious relationship. Curr. Opin. Pulm. Med. 18:517-523.
22. Kim, K.K., M.C. Kugler, P.J. Wolters, L. Robillard, M.G. Galvez, A.N. Brumwell, D. Sheppard, and H.A. Chapman. 2006. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. USA. 103:13180-13185. http://dx.doi.org/10.1073/pnas.0605669103
23. King, T.E. Jr., A. Pardo, and M. Selman. 2011. Idiopathic pulmonary fibrosis. Lancet. 378:1949-1961. http://dx.doi.org/10.1016/S0140-6736(11)60052-4
24. Koli, K., M. Myllärniemi, K. Vuorinen, K. Salmenkivi, M.J. Ryynänen, V.L. Kinnula, and J. Keski-Oja. 2006. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am. J. Pathol. 169:61-71. http://dx.doi.org/10.2353/ajpath.2006.051263
25. Le Luduec, J.B., T. Condamine, C. Louvet, P. Thebault, J.M. Heslan, M. Heslan, E. Chiffoleau, and M.C. Cuturi. 2008. An immunomodulatory role for follistatin-like 1 in heart allograft transplantation. Am. J. Transplant. 8:2297-2306. http://dx.doi.org/10.1111/j.1600-6143.2008.02398.x
26. Leask, A., and D.J. Abraham. 2004. TGF-β signaling and the fibrotic response. FASEB J. 18:816-827. http://dx.doi.org/10.1096/fj.03-1273rev
27. Li, M., M.S. Krishnaveni, C. Li, B. Zhou, Y. Xing, A. Banfalvi, A. Li, V. Lombardi, O. Akbari, Z. Borok, and P. Minoo. 2011. Epitheliumspecific deletion of TGF-β receptor type II protects mice from bleomycininduced pulmonary fibrosis. J. Clin. Invest. 121:277-287. http://dx.doi.org/10.1172/JCI42090
28. Li, L., X. Li, X. Liu, Y. Dong, Y. Geng, X. Liu, and W. Ning. 2013. Expression, characterization, and preliminary X-ray crystallographic analysis of recombinant murine Follistatin-like 1 expressed in Drosophila S2 cells. Biosci. Trends. 7:93-100.
29. Miyamae, T., A.D. Marinov, D. Sowders, D.C. Wilson, J. Devlin, R. Boudreau, P. Robbins, and R. Hirsch. 2006. Follistatin-like protein-1 is a novel proinflammatory molecule. J. Immunol. 177:4758-4762. http://dx.doi.org/10.4049/jimmunol.177.7.4758
30. Moeller, A., K. Ask, D. Warburton, J. Gauldie, and M. Kolb. 2008. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int. J. Biochem. Cell Biol. 40:362-382. http://dx.doi.org/10.1016/j.biocel.2007.08.011
31. Munger, J.S., X. Huang, H. Kawakatsu, M.J. Griffiths, S.L. Dalton, J. Wu, J.F. Pittet, N. Kaminski, C. Garat, M.A. Matthay, et al. 1999. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:319-328. http://dx.doi.org/10.1016/S0092-8674(00)80545-0
32. Myllärniemi, M., P. Lindholm, M.J. Ryynänen, C.R. Kliment, K. Salmenkivi, J. Keski-Oja, V.L. Kinnula, T.D. Oury, and K. Koli. 2008. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 177:321-329. http://dx.doi.org/10.1164/rccm.200706-945OC
33. Ning, W., C.J. Li, N. Kaminski, C.A. Feghali-Bostwick, S.M. Alber, Y.P. Di, S.L. Otterbein, R. Song, S. Hayashi, Z. Zhou, et al. 2004. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc. Natl. Acad. Sci. USA. 101: 14895-14900. http://dx.doi.org/10.1073/pnas.0401168101
34. Noble, P.W., and R.J. Homer. 2004. Idiopathic pulmonary fibrosis: new insights into pathogenesis. Clin. Chest Med. 25:749-758: vii. http://dx.doi.org/10.1016/j.ccm.2004.04.003
35. Olson, A.L., J.J. Swigris, D.C. Lezotte, J.M. Norris, C.G. Wilson, and K.K. Brown. 2007. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am. J. Respir. Crit. Care Med. 176:277-284. http://dx.doi.org/10.1164/rccm.200701-044OC
36. Pardo, A., K. Gibson, J. Cisneros, T.J. Richards, Y. Yang, C. Becerril, S. Yousem, I. Herrera, V. Ruiz, M. Selman, and N. Kaminski. 2005. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2:e251. http://dx.doi.org/10.1371/journal.pmed.0020251
37. Patella, S., D.J. Phillips, J. Tchongue, D.M. de Kretser, and W. Sievert. 2006. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G137-G144. http://dx.doi.org/10.1152/ajpgi.00080.2005
38. Phan, S.H. 2012. Genesis of the myofibroblast in lung injury and fibrosis. Proc. Am. Thorac. Soc. 9:148-152. http://dx.doi.org/10.1513/pats.201201-011AW
39. Rock, J.R., C.E. Barkauskas, M.J. Cronce, Y. Xue, J.R. Harris, J. Liang, P.W. Noble, and B.L. Hogan. 2011. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc. Natl. Acad. Sci. USA. 108:E1475-E1483. http://dx.doi.org/10.1073/pnas.1117988108
40. Saito, F., S. Tasaka, K. Inoue, K. Miyamoto, Y. Nakano, Y. Ogawa, W. Yamada, Y. Shiraishi, N. Hasegawa, S. Fujishima, et al. 2008. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am. J. Respir. Cell Mol. Biol. 38:566-571. http://dx.doi.org/10.1165/rcmb.2007-0299OC
41. Scotton, C.J., and R.C. Chambers. 2007. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest. 132:1311-1321. http://dx.doi.org/10.1378/chest.06-2568
42. Selman, M., and A. Pardo. 2002. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir. Res. 3:3. http://dx.doi.org/10.1186/rr175
43. Selman, M., A. Pardo, and N. Kaminski. 2008. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med. 5:e62. http://dx.doi.org/10.1371/journal.pmed.0050062
44. Shannon, J.M., and B.A. Hyatt. 2004. Epithelial-mesenchymal interactions in the developing lung. Annu. Rev. Physiol. 66:625-645. http://dx.doi.org/10.1146/annurev.physiol.66.032102.135749
45. Shibanuma, M., J. Mashimo, A. Mita, T. Kuroki, and K. Nose. 1993. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-β1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur. J. Biochem. 217:13-19. http://dx.doi.org/10.1111/j.1432-1033.1993.tb18212.x
46. Shimano, M., N. Ouchi, K. Nakamura, B. van Wijk, K. Ohashi, Y. Asaumi, A. Higuchi, D.R. Pimentel, F. Sam, T. Murohara, et al. 2011. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload. Proc. Natl. Acad. Sci. USA. 108:E899-E906. http://dx.doi.org/10.1073/pnas.1108559108
47. Sime, P.J., Z. Xing, F.L. Graham, K.G. Csaky, and J. Gauldie. 1997. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 100:768-776. http://dx.doi.org/10.1172/JCI119590
48. Sountoulidis, A., A. Stavropoulos, S. Giaglis, E. Apostolou, R. Monteiro, S.M. Chuva de Sousa Lopes, H. Chen, B.R. Stripp, C. Mummery, E. Andreakos, and P. Sideras. 2012. Activation of the canonical bone morphogenetic protein (BMP) pathway during lung morphogenesis and adult lung tissue repair. PLoS ONE. 7:e41460. http://dx.doi.org/10.1371/journal.pone.0041460
49. Trombetta-eSilva, J., and A.D. Bradshaw. 2012. The function of SPARC as a mediator of fibrosis. Open Rheumatol. J. 6:146-155. http://dx.doi.org/10.2174/1874312901206010146
50. Wang, X.M., Y. Zhang, H.P. Kim, Z. Zhou, C.A. Feghali-Bostwick, F. Liu, E. Ifedigbo, X. Xu, T.D. Oury, N. Kaminski, and A.M. Choi. 2006. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J. Exp. Med. 203:2895-2906. http://dx.doi.org/10.1084/jem.20061536
51. Willis, B.C., and Z. Borok. 2007. TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293:L525-L534. http://dx.doi.org/10.1152/ajplung.00163.2007
52. Wilson, M.S., and T.A. Wynn. 2009. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2:103-121. http://dx.doi.org/10.1038/mi.2008.85
53. Wynn, T.A. 2008. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214:199-210. http://dx.doi.org/10.1002/path.2277
54. Wynn, T.A. 2011. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208:1339-1350. http://dx.doi.org/10.1084/jem.20110551
55. Xu, J., X. Qi, J. Gong, M. Yu, F. Zhang, H. Sha, and X. Gao. 2012. Fstl1 antagonizes BMP signaling and regulates ureter development. PLoS ONE. 7:e32554. http://dx.doi.org/10.1371/journal.pone.0032554
56. Yang, J., S.E. Wheeler, M. Velikoff, K.R. Kleaveland, M.J. LaFemina, J.A. Frank, H.A. Chapman, P.J. Christensen, and K.K. Kim. 2013. Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins. Am. J. Pathol. 183:1559-1570. http://dx.doi. org/10.1016/j.ajpath.2013.07.016
57. Zhao, J., W. Shi, Y.L. Wang, H. Chen, P. Bringas Jr., M.B. Datto, J.P. Frederick, X.F. Wang, and D. Warburton. 2002. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L585-L593.
58. Zwijsen, A., H. Blockx, W. Van Arnhem, J. Willems, L. Fransen, K. Devos, J. Raymackers, A. Van de Voorde, and H. Slegers. 1994. Characterization of a rat C6 glioma-secreted follistatin-related protein (FRP). Cloning and sequence of the human homologue. Eur. J. Biochem. 225:937-946. http://dx.doi.org/10.1111/j.1432-1033.1994.0937b.x